BRIEF-Pharnext completes patient enrollment in Pivotal Phase 3 trial of PXT3003 for Charcot-Marie-Tooth Disease Type 1a

* Pharnext completes patient enrollment in international

pivotal phase 3 trial of PXT3003 for Charcot-Marie-Tooth Disease

Type 1a

Read more